GlassScriptPhysician profile
Christine Dotson
NPI 1942812771
$395.79
in general payments reported to CMS, 2019-2025
9 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $59.62 · 2024: $178 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $395.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $131.22 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Lilly USA, LLC | $100.17 | 2024 | Jardiance, Mounjaro |
| Exact Sciences Corporation | $36.34 | 2023-2024 | Cologuard Collection Kit |
| Amgen INC. | $33.86 | 2024 | Prolia, Evenity, Otezla |
| Abbvie INC. | $23.31 | 2023 | |
| Axsome Therapeutics, INC. | $21.43 | 2025 | Auvelity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.79 | 2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.24 | 2025 | Caplyta |
| Aimmune Therapeutics, INC. | $14.43 | 2025 | Zenpep |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Dotson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.